We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+0.84%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$9.62B
AUM Growth
+$9.12B
Cap. Flow
+$10.4B
Cap. Flow %
107.78%
Top 10 Hldgs %
35.81%
Holding
968
New
940
Increased
2
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
ROG icon
Rogers Corp
ROG
+$473M
2
ACC
American Campus Communities, Inc.
ACC
+$454M
3
CTXS
Citrix Systems Inc
CTXS
+$421M
4
SAIL
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
+$312M
5
CDK
CDK Global, Inc.
CDK
+$286M

Top Sells

Rank Stock Value
1
TGNA
TEGNA Inc
TGNA
+$1.1M

Sector Composition

Rank Sector Weight
1 Technology 27.77%
2 Financials 20.93%
3 Industrials 11.05%
4 Healthcare 9.88%
5 Communication Services 6.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PHAT icon
726
Phathom Pharmaceuticals
PHAT
$679M
$1.07M 0.01%
+127,093
New +$1.31M
SHFS icon
727
SHF Holdings
SHFS
$1.14M
$1.07M 0.01%
+5,056
New +$1.01M
ISEE
728
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$1.06M 0.01%
+109,750
New +$1.38M
GTY
729
Getty Realty Corp
GTY
$2.06B
$1.04M 0.01%
+39,281
New +$1.07M
PIPP
730
DELISTED
Pine Island Acquisition Corp.
PIPP
$1.04M 0.01%
+105,013
New +$1.04M
BPMC
731
DELISTED
Blueprint Medicines
BPMC
$1.03M 0.01%
+20,390
New +$1.19M
RACB
732
DELISTED
Research Alliance Corp. II Class A Common Stock
RACB
$1.03M 0.01%
+105,005
New +$1.03M
ROCL
733
DELISTED
Roth CH Acquisition V Co. Common Stock
ROCL
$1.03M 0.01%
+102,949
New +$1.02M
KPTI icon
734
Karyopharm Therapeutics
KPTI
$44.2M
$1.03M 0.01%
+15,173
New +$1.39M
ASAX
735
DELISTED
Astrea Acquisition Corp. Class A Common Stock
ASAX
$1.03M 0.01%
+105,005
New +$1.03M
CME icon
736
CME Group
CME
$95B
$1.02M 0.01%
+5,000
New +$1.06M
HWEL
737
DELISTED
Healthwell Acquisition Corp. I Class A Common Stock
HWEL
$1.02M 0.01%
+105,005
New +$1.02M
IVCP
738
DELISTED
Swiftmerge Acquisition Corp. Class A Ordinary Share
IVCP
$1.01M 0.01%
+102,949
New +$1.01M
ACAH
739
DELISTED
Atlantic Coastal Acquisition Corp. Class A Common Stock
ACAH
$1.01M 0.01%
+102,949
New +$1.01M
EWTX icon
740
Edgewise Therapeutics
EWTX
$4.78B
$995K 0.01%
+125,000
New +$945K
HLVX
741
DELISTED
HilleVax
HLVX
$994K 0.01%
+90,943
New +$1.08M
F icon
742
Ford
F
$55B
$991K 0.01%
+89,064
New +$1.22M
SHLS icon
743
Shoals Technologies Group
SHLS
$1.45B
$989K 0.01%
+59,985
New +$886K
GLUE icon
744
Monte Rosa Therapeutics
GLUE
$1.33B
$983K 0.01%
+101,647
New +$1.02M
BEPC icon
745
Brookfield Renewable
BEPC
$6.19B
$978K 0.01%
+27,473
New +$1.02M
LII icon
746
Lennox International
LII
$15.1B
$969K 0.01%
+4,691
New +$1.03M
BCYC
747
Bicycle Therapeutics
BCYC
$278M
$967K 0.01%
+57,625
New +$1.22M
INBX
748
DELISTED
Inhibrx, Inc. Common Stock
INBX
$965K 0.01%
+85,050
New +$1.25M
FLNC icon
749
Fluence Energy
FLNC
$2.44B
$948K 0.01%
+100,000
New +$973K
SCYX icon
750
SCYNEXIS
SCYX
$51.6M
$942K 0.01%
+63,280
New +$1.22M
28 29
30
31 32

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return

UBS O'Connor's Q2 2022 Portfolio in Review

As of Q2 2022, UBS O'Connor held 968 positions worth $9.62B, up 1,838% from $496M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

UBS O'Connor deployed $10.4B of net new capital in Q2 2022, opening 940 new positions and adding to 2 existing holdings. Its largest new stake was Rogers Corp: 1,780,443 shares worth $467M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 85% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was TEGNA Inc, an estimated $1.1M trimmed.

  • UBS O'Connor's largest Q2 2022 buy was Rogers Corp: 1,780,443 shares worth $467M.
  • UBS O'Connor added most to Activision Blizzard in Q2 2022, an estimated $107M increase.
  • UBS O'Connor's biggest Q2 2022 reduction was TEGNA Inc, cutting an estimated $1.1M.
  • UBS O'Connor's ten largest holdings make up 36% of its $9.62B portfolio in Q2 2022.
  • UBS O'Connor opened 940 new positions and closed 0 in Q2 2022.
  • UBS O'Connor's portfolio value rose 1,838% quarter-over-quarter to $9.62B.

Based on UBS O'Connor's 13F filing for Q2 2022, filed 12 Aug 2022.